Skip to main content
. 2011 Apr 28;6:905–913. doi: 10.2147/IJN.S17503

Figure 5.

Figure 5

Whole-blood analysis after treatment. Mice were injected daily via the tail vein with i) amphotericin B (AmB) (1 mg/kg), ii) polysorbate 80-coated amphotericin B-polybutylcyanoacrylate nanoparticles (AmB-PBCA-NPs) (3 mg/kg), iii) blank-PBCA-NPs (3 mg/kg), and iv) polysorbate 80 (1%). Indices: A) White blood cell count (WBC) (× 109/L); B) Red blood cell count (RBC) (×1012/L); C) hemoglobin (Hb) (g/L); D) platelet count (PLT) (×109/L).

Notes: **P < 0.01; *P < 0.05, value vs −1 day; b**P < 0.01, value vs that at 1 day; c**P < 0.01, AmB value vs Amb-PCNB-NP value on the same day; c*P < 0.05, AmB value vs Amb-PCNB-NP value on the same day. Values are given as the mean ± standard deviation (n = 10/group).